STOCK TITAN

NEXGEL (NXGL) CFO details warrants, convertible note and 160,000-share option

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

NEXGEL, INC. Chief Financial Officer Ian Howard Blackman filed an initial ownership report listing his derivative positions in the company’s common stock. The filing shows a warrant exercisable at $0.80 per share for 20,834 underlying shares, expiring on April 17, 2031, and a $25,000 convertible note convertible at $0.60 per share into 41,667 shares, expiring on October 17, 2027. It also discloses a stock option for 160,000 shares at an exercise price of $0.65 per share, expiring on April 27, 2031. According to the footnote, 40,000 option shares vest on April 27, 2027, with the remaining 120,000 vesting monthly over 36 months starting March 31, 2027, subject to continued service and potential acceleration upon a Change in Control.

Positive

  • None.

Negative

  • None.
Insider Blackman Ian Howard
Role Chief Financial Officer
Type Security Shares Price Value
holding Stock Option (right to buy) -- -- --
holding $25,000 Convertible Note (right to buy) -- -- --
holding Warrant (right to buy) -- -- --
Holdings After Transaction: Stock Option (right to buy) — 160,000 shares (Direct, null); $25,000 Convertible Note (right to buy) — 41,667 shares (Direct, null); Warrant (right to buy) — 20,834 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Warrant exercise price $0.80 per share Warrant for 20,834 underlying common shares, expires April 17, 2031
Warrant underlying shares 20,834 shares Common stock underlying CFO warrant position
Convertible note amount $25,000 Convertible into 41,667 common shares at $0.60 per share
Convertible note conversion price $0.60 per share Conversion price for 41,667 underlying common shares
Stock option size 160,000 shares Option grant under 2019 Long-Term Incentive Plan
Stock option exercise price $0.65 per share Exercise price for 160,000-share option expiring April 27, 2031
Initial vesting tranche 40,000 shares Option shares vesting on April 27, 2027
Remaining vesting period 36 months 120,000 option shares vest monthly from March 31, 2027
Warrant (right to buy) financial
"security_title: "Warrant (right to buy)" with 20,834 underlying shares"
Convertible Note financial
""$25,000 Convertible Note (right to buy)" convertible at $0.60 per share"
A convertible note is a type of loan that a company gets from investors, which can later be turned into company shares instead of being paid back in cash. It matters because it helps startups raise money quickly without setting a fixed value for the company right away, making it easier to grow and attract investors.
Stock Option financial
""Stock Option (right to buy)" for 160,000 underlying common shares"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
2019 Long-Term Incentive Plan financial
"granted pursuant to the Issuer's 2019 Long-Term Incentive Plan, as amended"
Change in Control financial
"In the event of a Change in Control (as defined in the Plan)"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
vesting date financial
"subject to the Reporting Person's continuous service through each vesting date"
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Blackman Ian Howard

(Last)(First)(Middle)
C/O NEXGEL, INC.
2150 CABOT BOULEVARD, WEST, SUITE B

(Street)
LANGHORNE PENNSYLVANIA 19047

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
04/27/2026
3. Issuer Name and Ticker or Trading Symbol
NEXGEL, INC. [ NXGL ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy) (1)04/27/2031Common Stock160,000$0.65D
$25,000 Convertible Note (right to buy)04/17/202610/17/2027Common Stock41,667$0.6D
Warrant (right to buy)04/17/202604/17/2031Common Stock20,834$0.8D
Explanation of Responses:
1. Represents a stock option granted pursuant to the Issuer's 2019 Long-Term Incentive Plan, as amended (the "Plan"), for services as the Issuer's Chief Financial Officer. The number of shares underlying the stock option shall vest as follows: (i) 40,000 shares of common stock vest on April 27, 2027 and (ii) the remaining 120,000 shares of common stock vest equally per month on the last day of each month for thirty-six months beginning on March 31, 2027 (with 3,334 shares vesting per month and 3,310 shares vesting on month thirty-six due to rounding adjustments), subject to the Reporting Person's continuous service through each vesting date. In the event of a Change in Control (as defined in the Plan), any unvested shares underlying the stock option shall accelerate in accordance with the terms of the Plan.
/s/ Ian Howard Blackman05/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does NEXGEL (NXGL) CFO Ian Blackman report on this Form 3?

He reports existing derivative holdings linked to NEXGEL common stock, including a warrant, a $25,000 convertible note, and a stock option grant. These entries show his current rights to acquire shares, not new open‑market purchases or sales.

How many NEXGEL (NXGL) shares are underlying the CFO’s warrant and note?

The warrant is exercisable into 20,834 NEXGEL common shares at $0.80 per share. The $25,000 convertible note is convertible into 41,667 common shares at $0.60 per share, based on the disclosed conversion terms.

What are the key terms of the NEXGEL (NXGL) CFO’s stock option grant?

The stock option covers 160,000 NEXGEL common shares at an exercise price of $0.65 per share, expiring on April 27, 2031. It was granted under the 2019 Long-Term Incentive Plan for his services as Chief Financial Officer.

How does the vesting schedule work for the NEXGEL (NXGL) CFO’s 160,000-share option?

The option vests in stages: 40,000 shares vest on April 27, 2027. The remaining 120,000 shares vest equally each month over 36 months starting March 31, 2027, contingent on continuous service through each vesting date.

What happens to the NEXGEL (NXGL) CFO’s options if there is a Change in Control?

The footnote states any unvested shares underlying the stock option may accelerate upon a Change in Control, as defined in NEXGEL’s 2019 Long-Term Incentive Plan. Acceleration would follow the plan’s terms, potentially making unvested options vest earlier.

Does this NEXGEL (NXGL) Form 3 show the CFO buying or selling shares?

No, it lists existing derivative positions rather than new market trades. The entries reflect a warrant, a convertible note, and stock options with defined exercise prices and expirations, showing what the CFO can acquire, not recent purchases or sales.